Coronary artery dilation among patients with paediatric-onset systemic lupus erythematosus

References

• Fairhurst AM, Wandstrat AE, Wakeland EK. Systemic lupus erythematosus: multiple immunologic phenotypes in a complex genetic disease. Adv Immunol 2006;92:1–69.
   PubMed Web of Science ®Google Scholar
• Tucker LB, Menon S, Schaller JG, Isenberg DA. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 1995;34:866–72.
   PubMedGoogle Scholar
• Huang JL, Lin CJ, Hung IJ, Luo SF. The morbidity and mortality associated with childhood onset systemic lupus erythematosus. Chang Gung Med J 1994;17:113–20.
   Google Scholar
• Wei HY, Chung HT, Wu CT, Huang JL. Aortic dissection complicated with hemothorax in an adolescent patient with systemic lupus erythematosus: case report and review of literature. Semin Arthritis Rheum 2011;41:12–18.
   Google Scholar
• Asanuma Y, Oeser A, Shintani AK, Turner E, Olsen N, Fazio S, . Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2407–15.
   PubMed Web of Science ®Google Scholar
• Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, . Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001;44:2331–7.
   PubMed Web of Science ®Google Scholar
• Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT, Criqui MH, . Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation 2000;101:E16–22.
   PubMedGoogle Scholar
• Binstadt BA, Levine JC, Nigrovic PA, Gauvreau K, Dedeoglu F, Fuhlbrigge RC, . Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic arthritis. Pediatrics 2005;116:e89–93.
   PubMed Web of Science ®Google Scholar
• Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006;440:237–41.
   PubMed Web of Science ®Google Scholar
• Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008;359:1811–21.
   PubMed Web of Science ®Google Scholar
• Huang YL, Chug HT, Chang CJ, Yeh KW, Chen LC, Huang JL. Lymphopenia is a risk factor in the progression of carotid intima-media thickness in juvenile-onset systemic lupus erythematosus. Arthritis Rheum 2009;60:3766–75.
   PubMedGoogle Scholar
• Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, . The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271–7.
   PubMed Web of Science ®Google Scholar
• National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114(Suppl):555–76.
   Google Scholar
• Ingegnoli F, Zeni S, Gerloni V, Fantini F. Capillaroscopic observations in childhood rheumatic diseases and healthy controls. Clin Exp Rheumatol 2005;23:905–11.
   PubMed Web of Science ®Google Scholar
• Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang DH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630–40.
   PubMed Web of Science ®Google Scholar
• de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be classified as normal in Kawasaki disease. J Pediatr 1998;133:254–8.
   PubMed Web of Science ®Google Scholar
• Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, . Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996;94:1379–85.
   PubMed Web of Science ®Google Scholar
• Kadono T, Sugiyama H, Hoshiai M, Osada M, Tan T, Naitoh A, . Endothelial function evaluated by flow-mediated dilatation in pediatric vascular disease. Pediatr Cardiol 2005;26:385–90.
   PubMed Web of Science ®Google Scholar
• Ikemoto Y, Ogino H, Teraguchi M, Kobayashi Y. Evaluation of preclinical atherosclerosis by flow-mediated dilatation of the brachial artery and carotid artery analysis in patients with a history of Kawasaki disease. Pediatr Cardiol 2005;26:782–6.
   Google Scholar
• Cypiene A, Kovaite M, Venalis A, Dadoniene J, Rugiene R, Petrulioniene Z, . Arterial wall dysfunction in systemic lupus erythematosus. Lupus 2009;18:522–9.
   PubMed Web of Science ®Google Scholar
• Karadag O, Calguneri M, Atalar E, Yavuz B, Akdogan A, Kalyoncu U, . Novel cardiovascular risk factors and cardiac event predictors in female inactive systemic lupus erythematosus patients. Clin Rheumatol 2007;26:695–9.
   PubMedGoogle Scholar
• Sabry A, Sheashaa H, El-Husseini A, Mahmoud K, Eldahshan KF, George SK, . Pro-inflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: its correlation with disease activity. Cytokine 2006;35:148–53.
   PubMed Web of Science ®Google Scholar
• Chien YH, Chang KW, Yang YH, Lu MY, Lin YT, Chiang BL. Association between levels of TNF-alpha and TNF-alpha promoter -308 A/A polymorphism in children with Kawasaki disease. J Formos Med Assoc 2003;102:147–50.
   PubMedGoogle Scholar
• Diniz JC, Almeida RT, Aikawa NE, Sallum AM, Sakane PT, Silva CA. Kawasaki disease and juvenile systemic lupus erythematosus. Lupus 2012;21:89–92.
   Google Scholar
• Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, . Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997;145:408–15.
   PubMed Web of Science ®Google Scholar
• Schanberg LE, Sandborg C, Barnhart HX, Ardoin SP, Yow E, Evans GW, . Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis Rheum 2009;60:1496–507.
   PubMed Web of Science ®Google Scholar
• Karrar A, Sequeira W, Block JA. Coronary artery disease in systemic lupus erythematosus: a review of the literature. Semin Arthritis Rheum 2001;30:436–43.
   PubMedGoogle Scholar
• Korkmaz C, Cansu DU, Kaşifoğlu T. Myocardial infarction in young patients (≤35 years of age) with systemic lupus erythematosus: a case report and clinical analysis of the literature. Lupus 2007;16:289–97.
   Web of Science ®Google Scholar
• Caracciolo EA, Marcu CB, Ghantous A, Donohue TJ, Hutchinson G. Coronary vasculitis with acute myocardial infarction in a young woman with systemic lupus erythematosus. J Clin Rheumatol 2004;10:66–8.
   Web of Science ®Google Scholar
• Cannon PJ, Stason WB, Demartini FE, Sommers SC, Laragh JH. Hyperuricemia in primary and renal hypertension. N Engl J Med 1966;275:457–64.
   PubMed Web of Science ®Google Scholar
• Ford ES, Li C, Cook S, Choi HK. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 2007;115:2526–32.
   PubMed Web of Science ®Google Scholar
• Tuttle KR, Short RA, Johnson RJ. Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol 2001;87:1411–14.
   PubMed Web of Science ®Google Scholar
• Siu YP, Leung KT, Tong MK, Kwan TH. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 2006;47:51–9.
   PubMed Web of Science ®Google Scholar
• Sen N, Ozcan F, Uygur B, Aksu T, Akpinar I, Cay S, . Elevated serum uric acid levels in patients with isolated coronary artery ectasia [in Turkish]. Arch Turk Soc Cardiol 2009;37:467–72.
   PubMedGoogle Scholar
• Niskanen LK, Laaksonen DE, Nyyssonen K, Alfthan G, Lakka HM, Lakka TA, . Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004;164:1546–51.
   PubMed Web of Science ®Google Scholar
• Feig DI, Johnson RJ. Hyperuricemia in childhood primary hypertension. Hypertension 2003;42:247–52.
   PubMed Web of Science ®Google Scholar
• Yang Z, Liang Y, Xi W, Zhu Y, Li C, Zhong R. Association of serum uric acid with lupus nephritis in systemic lupus erythematosus. Rheumatol Int 2011;31:743–8.
   Google Scholar
• Kahlenberg JM, Thacker SG, Berthier CC, Cohen CD, Kretzler M, Kaplan MJ. Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus. J Immunol 2011;187:6143–56.
   PubMed Web of Science ®Google Scholar